Video
By Memorial Sloan-Kettering  |  Wednesday, April 4, 2012

Michael was diagnosed with acute myelogenous leukemia at age 16. After receiving treatment in the Department of Pediatrics he is a cancer survivor and college student, looking forward to “taking the artistic field by force.”

Pictured: Ross Levine
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, March 15, 2012

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.